Hematopoietic Recovery after in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant-Effects of Major ABO Incompatibility, CMV Viremia and Acute Gvhd

Faculty of Medicine

Assiut University

Hematopoietic Recovery after in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant-Effects of Major ABO Incompatibility, CMV Viremia and Acute Gvhd

Research Authors
Ronit Reich Slotky, Naima Al-Mulla, Rania Hafez, Javier Segovia, Sebastian Mayer, Adrienne Phillips, Tsiporah B Shore, Jingmei Hsu, Yen-Michael Sheng Hsu, Ljiljana V Vasovic, Ruchika Goel, Melissa Cushing, Koen van Besien, Usama Gergis
Research Department
Internal Medicine
Research Journal
Biology of Blood and Marrow Transplantation
Research Member
Rania Mohamed Mahmoud Hafez
Research Publisher
Elsevier
Research Rank
3
Research Vol
24(3)
Research Website
NULL
Research Year
2018
Research_Pages
S337
Research Abstract

Background: Transfusion support after allogeneic transplantation is closely associated with morbidity, cost and may also affect long-term outcome. To better predict the determinants of hematopoietic recovery of allogeneic hematopoietic stem cell transplantation (HSCT) recipients, we analyzed 214 consecutive patients at our institution from January 2012 to December 2013.